Ria International India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 13 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 11.81%
(FY 2021)
- Profit 61.10%
(FY 2021)
- Ebitda -22.97%
(FY 2021)
- Net Worth 33.58%
(FY 2021)
- Total Assets 9.81%
(FY 2021)
About Ria International India
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vivek Grover and Pardeep Sethi serve as directors at the Company.
- CIN/LLPIN
U51103MH2011PTC221946
- Company No.
221946
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Sep 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Ria International India Private Limited offer?
Ria International India Private Limited offers a wide range of products and services, including Herbal Extracts, Plant Extracts, Fertilizers and Soil Additives, Organic Fertilizers and Manure, Common Disease Medicines, Pharmaceutical Medicine.
Who are the key members and board of directors at Ria International India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Grover  | Director | 13-Sep-2011 | Current |
Pardeep Sethi  | Director | 10-Jan-2012 | Current |
Financial Performance of Ria International India.
Ria International India Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 11.81% increase. The company also saw a substantial improvement in profitability, with a 61.1% increase in profit. The company's net worth Soared by an impressive increase of 33.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ria International India?
In 2021, Ria International India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Organosynth Chemicals And Pharmaceuticals Private LimitedActive 2 years 8 monthsVivek Grover and Pardeep Sethi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ria International India?
Unlock and access historical data on people associated with Ria International India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ria International India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ria International India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
